Home
/
MEDIFAST INC
/
Financials
/
Quarterly
MEDIFAST INC — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that MEDIFAST INC filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2022
Sep 30, 2022
$390.40M
Nov 3, 2022
Q2
2022
Jun 30, 2022
$453.33M
Aug 3, 2022
Q1
2022
Mar 31, 2022
$417.60M
May 2, 2022
Q3
2022
Sep 30, 2021
$413.40M
Nov 3, 2022
Q2
2022
Jun 30, 2021
$394.19M
Aug 3, 2022
Q1
2022
Mar 31, 2021
$340.67M
May 2, 2022
Q3
2021
Sep 30, 2020
$271.47M
Nov 4, 2021
Q2
2021
Jun 30, 2020
$220.00M
Aug 4, 2021
Q1
2021
Mar 31, 2020
$178.46M
May 4, 2021
Q3
2020
Sep 30, 2019
$190.06M
Nov 3, 2020
Q2
2020
Jun 30, 2019
$187.10M
Aug 6, 2020
Q1
2020
Mar 31, 2019
$165.88M
May 6, 2020
Q3
2019
Sep 30, 2018
$139.24M
Nov 8, 2019
Q2
2019
Jun 30, 2018
$117.32M
Aug 2, 2019
Q1
2019
Mar 31, 2018
$98.60M
May 2, 2019
Q3
2018
Sep 30, 2017
$77.21M
Nov 7, 2018
Q2
2018
Jun 30, 2017
$75.73M
Aug 6, 2018
Q1
2018
Mar 31, 2017
$70.62M
May 4, 2018
Q3
2017
Sep 30, 2016
$68.58M
Nov 8, 2017
Q2
2017
Jun 30, 2016
$71.14M
Aug 9, 2017
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$89.41M
Nov 3, 2025
Q2
2025
Jun 30, 2025
$105.56M
Aug 4, 2025
Q1
2025
Mar 31, 2025
$115.73M
Apr 28, 2025
Q3
2025
Sep 30, 2024
$140.16M
Nov 3, 2025
Q2
2025
Jun 30, 2024
$168.56M
Aug 4, 2025
Q1
2025
Mar 31, 2024
$174.74M
Apr 28, 2025
Q3
2024
Sep 30, 2023
$235.87M
Nov 4, 2024
Q2
2024
Jun 30, 2023
$296.19M
Aug 5, 2024
Q1
2024
Mar 31, 2023
$348.98M
Apr 29, 2024
Q3
2023
Sep 30, 2022
$390.40M
Nov 6, 2023
Q2
2023
Jun 30, 2022
$453.33M
Aug 7, 2023
Q1
2023
Mar 31, 2022
$417.60M
May 1, 2023
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2017
Sep 30, 2017
$77.21M
Nov 8, 2017
Q2
2017
Jun 30, 2017
$75.73M
Aug 9, 2017
Q1
2017
Mar 31, 2017
$70.62M
May 10, 2017
Q3
2017
Sep 30, 2016
$68.58M
Nov 8, 2017
Q2
2017
Jun 30, 2016
$71.14M
Aug 9, 2017
Q1
2017
Mar 31, 2016
$72.35M
May 10, 2017
Q3
2016
Sep 30, 2015
$65.94M
Nov 9, 2016
Q2
2016
Jun 30, 2015
$72.16M
Aug 9, 2016
Q1
2016
Mar 31, 2015
$73.36M
May 10, 2016
Q3
2015
Sep 30, 2014
$69.02M
Nov 9, 2015
Q2
2015
Jun 30, 2014
$74.73M
Aug 10, 2015
Q1
2015
Mar 31, 2014
$79.23M
May 11, 2015
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($2.26M)
Nov 3, 2025
Q3
2025
Jun 30, 2025
$2.48M
Nov 3, 2025
Q2
2025
Jun 30, 2025
$2.48M
Aug 4, 2025
Q3
2025
Mar 31, 2025
($772.0K)
Nov 3, 2025
Q2
2025
Mar 31, 2025
($772.0K)
Aug 4, 2025
Q1
2025
Mar 31, 2025
($772.0K)
Apr 28, 2025
Q3
2025
Sep 30, 2024
$1.13M
Nov 3, 2025
Q3
2025
Jun 30, 2024
($8.15M)
Nov 3, 2025
Q2
2025
Jun 30, 2024
($8.15M)
Aug 4, 2025
Q1
2025
Mar 31, 2024
$8.32M
Apr 28, 2025
Q2
2025
Mar 31, 2024
$8.32M
Aug 4, 2025
Q3
2025
Mar 31, 2024
$8.32M
Nov 3, 2025
Q3
2024
Sep 30, 2023
$23.13M
Nov 4, 2024
Q3
2024
Jun 30, 2023
$30.28M
Nov 4, 2024
Q2
2024
Jun 30, 2023
$30.28M
Aug 5, 2024
Q3
2024
Mar 31, 2023
$39.97M
Nov 4, 2024
Q1
2024
Mar 31, 2023
$39.97M
Apr 29, 2024
Q2
2024
Mar 31, 2023
$39.97M
Aug 5, 2024
Q3
2023
Sep 30, 2022
$36.16M
Nov 6, 2023
Q2
2023
Jun 30, 2022
$39.11M
Aug 7, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($4.08M)
Nov 3, 2025
Q2
2025
Jun 30, 2025
($1.07M)
Aug 4, 2025
Q1
2025
Mar 31, 2025
($1.26M)
Apr 28, 2025
Q3
2025
Sep 30, 2024
$2.11M
Nov 3, 2025
Q2
2025
Jun 30, 2024
($7.88M)
Aug 4, 2025
Q1
2025
Mar 31, 2024
$7.94M
Apr 28, 2025
Q3
2024
Sep 30, 2023
$25.51M
Nov 4, 2024
Q2
2024
Jun 30, 2023
$38.71M
Aug 5, 2024
Q1
2024
Mar 31, 2023
$53.51M
Apr 29, 2024
Q3
2023
Sep 30, 2022
$48.16M
Nov 6, 2023
Q2
2023
Jun 30, 2022
$48.96M
Aug 7, 2023
Q1
2023
Mar 31, 2022
$55.09M
May 1, 2023
Q3
2022
Sep 30, 2021
$55.17M
Nov 3, 2022
Q2
2022
Jun 30, 2021
$61.43M
Aug 3, 2022
Q1
2022
Mar 31, 2021
$52.80M
May 2, 2022
Q3
2021
Sep 30, 2020
$44.56M
Nov 4, 2021
Q2
2021
Jun 30, 2020
$28.10M
Aug 4, 2021
Q1
2021
Mar 31, 2020
$23.53M
May 4, 2021
Q3
2020
Sep 30, 2019
$20.26M
Nov 3, 2020
Q2
2020
Jun 30, 2019
$27.36M
Aug 6, 2020